» Articles » PMID: 31453371

Engineered Models to Parse Apart the Metastatic Cascade

Overview
Publisher Springer Nature
Specialty Oncology
Date 2019 Aug 28
PMID 31453371
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

While considerable progress has been made in studying genetic and cellular aspects of metastasis with in vitro cell culture and in vivo animal models, the driving mechanisms of each step of metastasis are still relatively unclear due to their complexity. Moreover, little progress has been made in understanding how cellular fitness in one step of the metastatic cascade correlates with ability to survive other subsequent steps. Engineered models incorporate tools such as tailored biomaterials and microfabrication to mimic human disease progression, which when coupled with advanced quantification methods permit comparisons to human patient samples and in vivo studies. Here, we review novel tools and techniques that have been recently developed to dissect key features of the metastatic cascade using primary patient samples and highly representative microenvironments for the purposes of advancing personalized medicine and precision oncology. Although improvements are needed to increase tractability and accessibility while faithfully simulating the in vivo microenvironment, these models are powerful experimental platforms for understanding cancer biology, furthering drug screening, and facilitating development of therapeutics.

Citing Articles

Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.

Leung M, Swanton C, McGranahan N Nat Rev Genet. 2025; .

PMID: 40065153 DOI: 10.1038/s41576-025-00825-2.


Prolonged DEHP exposure enhances the stemness and metastatic potential of TNBC cells in an MSI2-dependent manner.

Jadhao M, Hsu S, Deshmukh D, Liu P, Weng S, Chen Y Int J Biol Sci. 2025; 21(4):1705-1729.

PMID: 39990676 PMC: 11844279. DOI: 10.7150/ijbs.101598.


Seryl-tRNA synthetase inhibits Wnt signaling and breast cancer progression and metastasis.

Jiang L, Wang J, Liu Z, Zhang Q, Yang X FASEB J. 2025; 39(1):e70294.

PMID: 39760229 PMC: 11817322. DOI: 10.1096/fj.202401720R.


Current preclinical models of brain metastasis.

Drouin Z, Levesque F, Mouzakitis K, Labrie M Clin Exp Metastasis. 2024; 42(1):5.

PMID: 39694975 DOI: 10.1007/s10585-024-10318-x.


Development of a Microphysiological System to Model Human Cancer Metastasis From the Colon to the Liver.

Miller P, Huang E, Fisher R, Shuler M Biotechnol Bioeng. 2024; 122(3):481-494.

PMID: 39587032 PMC: 11810609. DOI: 10.1002/bit.28890.


References
1.
Staton C, Reed M, Brown N . A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol. 2009; 90(3):195-221. PMC: 2697546. DOI: 10.1111/j.1365-2613.2008.00633.x. View

2.
Yue X, Nguyen T, Zellmer V, Zhang S, Zorlutuna P . Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions. Biomaterials. 2018; 170:37-48. DOI: 10.1016/j.biomaterials.2018.04.001. View

3.
Bersini S, Miermont A, Pavesi A, Kamm R, Thiery J, Moretti M . A combined microfluidic-transcriptomic approach to characterize the extravasation potential of cancer cells. Oncotarget. 2018; 9(90):36110-36125. PMC: 6281425. DOI: 10.18632/oncotarget.26306. View

4.
Au S, Storey B, Moore J, Tang Q, Chen Y, Javaid S . Clusters of circulating tumor cells traverse capillary-sized vessels. Proc Natl Acad Sci U S A. 2016; 113(18):4947-52. PMC: 4983862. DOI: 10.1073/pnas.1524448113. View

5.
Klimkiewicz K, Weglarczyk K, Collet G, Paprocka M, Guichard A, Sarna M . A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection. Cancer Lett. 2017; 396:10-20. DOI: 10.1016/j.canlet.2017.03.006. View